Related content

Expression of high-risk HPV DNA and CK19 in pelvic lymph nodes in stage a-a cervical cancer and their clinical value

By              

Oncology Reports, Vol. 27, Iss. 6, 2012-01 ,pp. : 1801-1806

Spandidos Publications

Access to resources Recommend Favorite

Parametrial Spread of Cervical Cancer in Patients with Negative Pelvic Lymph Nodes

By Winter R.   Haas J.   Reich O.   Koemetter R.   Tamussino K.   Lahousen M.   Petru E.   Pickel H.  

Gynecologic Oncology, Vol. 84, Iss. 2, 2002-02 ,pp. : 252-257

Elsevier

Access to resources Recommend Favorite

Determining and visualising at-risk groups in case-control data

By Marshall R. J.  

Journal of Epidemiology and Biostatistics, Vol. 6, Iss. 4, 2001-07 ,pp. : 343-348

Taylor & Francis Ltd

Access to resources Recommend Favorite

Role of stereotactic body radiotherapy in spinal metastasis and subsequent fracture risk: identifying and treating the at-risk patient

By Anwar Mekhail   Barani Igor J  

CNS Oncology, Vol. 2, Iss. 5, 2013-09 ,pp. : 437-445

Future Medicine

Access to resources Recommend Favorite

Stage IB and IIA Cervical Cancer with Negative Lymph Nodes: The Role of Adjuvant Radiotherapy after Radical Hysterectomy

By Schorge J.O.   Molpus K.L.   Koelliker D.   Nikrui N.   Goodman A.   Fuller A.F.  

Gynecologic Oncology, Vol. 66, Iss. 1, 1997-07 ,pp. : 31-35

Elsevier

Access to resources Recommend Favorite